Outcome of Board Meeting held on May 19, 2026
BHAGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The board approved audited standalone and consolidated financial results for FY2026 ended March 31, 2026. Standalone revenue grew 19.4% to Rs 52,122 lakhs but PAT declined 4.2% to Rs 2,624 lakhs. Consolidated revenue rose 21.7% to Rs 53,594 lakhs with PAT up 31.1% to Rs 1,817 lakhs, boosted by subsidiary Bheema Fine Chemicals. The board recommended final dividend of Rs 0.15 per share (15%) for FY2026, unchanged from prior year, subject to shareholder approval at the 33rd AGM on July 31, 2026. Statutory auditors issued unmodified (clean) opinions on both standalone and consolidated results.
Revenue growth is solid but standalone profit declined despite higher sales, indicating margin compression. The consolidated PAT growth of 31% is positive but the standalone profit decline may concern investors focused on parent company performance. The unchanged dividend maintains shareholder returns.